ArticleFrontiers in physiology2026
Role of certain adipokines in the pathophysiology of hypertension.
Article in Frontiers in physiology, 2026. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Not yet cited in PubMed.
What it found
Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.
The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.
The trial behind it
Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.
Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.
Who cites it
0 citing papers in PubMed.
No citing paper in PubMed yet.
Corrections and comments
PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.
Authors and funding
3 authors.
Funding
No grant is acknowledged in the PubMed record.
Abstract
Introduction: Adipose tissue is an active endocrine organ that secretes adipokines involved in metabolic regulation, inflammation, and cardiovascular homeostasis. Increasing evidence suggests that adipokine imbalance may contribute to the development of hypertension. This study aimed to compare circulating adipokine levels in newly diagnosed untreated hypertensive patients and normaotensive controls and to evaluate their association with blood pressure. Methods: This case-control study included 180 participants recruited from outpatient clinics at Dicle University Faculty of Medicine. The study population consisted of 96 newly diagnosed untreated hypertensive patients and 84 normotensive controls. Sociodemographic data and blood pressure measurements were recorded. Serum levels of leptin, intelectin, RBP-1, chemerin, visceral adipokine index, adiponectin, resistin, visfatin, and C-reactive protein were measured using ELISA kits. Statistical analyses included group comparisons, correlation analyses, ANCOVA adjusted for age, sex, and body mass index (BMI), and multivariate logistic regression. Results: Leptin, intelectin, RBP-1, resistin, and visfatin levels were significantly higher in hypertensive patients than in controls (p < 0.001). Adiponectin levels were slightly higher in hypertensive individuals, while chemerin, visceral adipokine index, and CRP showed no significant differences. Logistic regression analysis identified age, BMI, and resistin as independent predictors of hypertension. Conclusion: Several adipokines are elevated in hypertension, suggesting a potential role in blood pressure regulation. Among them, resistin appears to be an independent predictor of hypertension and may represent a potential biomarker for cardiovascular risk assessment.
Indexed as
Identifiers
What OpenQuestion holds
Registered trials
Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.